Amid Rising Covid Fears, Wait For Patent Waiver On Meds Continues

“A partial patent waiver that frees generics companies to supply countries that cannot afford pharma-excessive ‘tiered prices’ is of utmost importance,” Professor Brook Baker, senior policy analyst for Health GAP, tells TIMES Special.